7.15
+0.10
+(1.42%)
At close: April 17 at 8:01:43 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 3 |
| Avg. Estimate | 240.9M | 265.57M | 1.05B | 1.12B |
| Low Estimate | 239.8M | 249.14M | 991.45M | 1.06B |
| High Estimate | 242M | 282M | 1.08B | 1.21B |
| Year Ago Sales | 270.32M | 274.75M | 1.05B | 1.05B |
| Sales Growth (year/est) | -10.88% | -3.34% | -0.23% | 7.44% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| HLX.F | -- | -- | -- | -- |
| S&P 500 | 7.04% | 4.85% | 8.57% | 14.16% |
Upgrades & Downgrades
| Maintains | Barclays: Underweight to Underweight | 4/2/2025 |
| Maintains | Barclays: Underweight to Underweight | 11/13/2024 |
| Maintains | Barclays: Underweight to Underweight | 11/4/2024 |
| Maintains | UBS: Neutral to Neutral | 10/30/2024 |
| Maintains | Barclays: Underweight to Underweight | 8/1/2024 |
| Downgrade | UBS: Buy to Neutral | 7/9/2024 |